Diagnostic Advisory Board
Clinical Diagnostics
8
3
Voice-of-Customer Research
KOL Identification
Objective
A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market
Our Approach
DeciBio recruited and coordinated the scheduling for 8 oncology KOLs (both oncologists and pathologists) for a 3-hour virtual ad board. With input from the client, DeciBio prepared the questionnaire and stimuli for the attendees and facilitated the discussion.
Outcome
DeciBio delivered a recording and written summary of the ad board discussion. The summary included key takeaways related to:
- Current use of genomic profiling assays in routine care
- Factors that drive test differentiation
- Evolution of current offering and potential future offerings
- Tradeoffs and differentiating features of various evolutions
- Competitor feedback and drivers of switching
- Perceived value of potential new features and ancillary offerings
Related Client Results
CDD on Novel Handheld Diagnostic Device Manufacturer
Voice-of-Customer Research
KOL Identification
Pricing Strategy
Revenue Projection
Due Diligence
RNA-based Oncology Biomarker Market Landscape
Voice-of-Customer Research
Competitive Analysis
Biomarker and Diagnostics Strategy
Product Specification Mapping
Cell Therapy Market Trends and Revenue Forecast
Revenue Projection
